Diabetes

Night shifts and unhealthy lifestyles both increase risk of T2DM

Researchers have found evidence suggesting that the benefits of adhering to a healthy lifestyle could be even greater in people who work rotating night shifts.…

Patients diagnosed with type 2 diabetes to be put on 800-calorie diet in new NHS pilot

People diagnosed with type 2 diabetes will be placed on a new low-calorie diet as part of a pilot scheme to treat the condition, NHS England has announced.…

Weight loss drug reduces risk of diabetes in overweight and obese people

Taking lorcaserin and making lifestyle changes can help prevent diabetes in people who are overweight or obese, study findings indicate.…

NHS England to fund flash glucose monitoring devices for all eligible diabetes patients

All patients with diabetes who qualify for a flash glucose monitoring device will be able to receive it on prescription from April 2019, NHS England has announced.…

Lack of evidence to support statin use in non-cardiovascular conditions

There is a lack of ‘convincing’ evidence that statins improve outcomes in non-cardiovascular conditions, such as diabetes, a review has shown.…

Reducing suboptimal prescribing of glucagon-like peptide mimetics in type 2 diabetes

In 2016, spend on diabetes prescribing — and glucagon-like peptide 1 (GLP-1) mimetics, in particular — at NHS Hastings and Rother Clinical Commissioning Group (CCG) and NHS Eastbourne, Hailsham and Seaford CCG was significantly higher than expected, based on national prescribing pat…

Hospital medication errors affected 260,000 diabetes patients in 2017

Around 260,000 patients with diabetes experienced a medication error during a hospital stay in 2017, according to analysis published by the charity Diabetes UK.…

Continuing metformin when introducing sulfonylureas is safer than switching in T2DM, research shows

Switching to sulfonylureas increases the risk of serious adverse events compared with remaining on metformin in people with type 2 diabetes mellitus, according to research published in The BMJ.…

Insulin degludec significantly improves blood sugar control compared with insulin glargine, data show

Using electronic health record data, researchers found that HbA1c levels declined by 1.5% among insulin degludec-treated patients compared with 1.2% in those treated with insulin glargine U300 over six months.…

Glucose-lowering therapy does not slow progression in young people with type 2 diabetes

Treatment with glucose-lowering therapy does not maintain or improve pancreatic beta-cell function in young people recently diagnosed with impaired glucose tolerance or type 2 diabetes mellitus, a study has shown.…